DBVT Overview
Upcoming Projects (DBVT)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (DBVT)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (DBVT)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (DBVT)
-
DBV Technologies (DBVT) Announces Marketing Authorization Application Approval for Viaskin Peanut by European Medicines Agency
Ticker: DBVT
Occurred on: Nov 02, 2020 -
DBV Technologies to report topline results from Phase 3 PEPITES of Viaskin Peanut in Peanut allergy in October 2017
Ticker: DBVT
Occurred on: Oct 20, 2017 -
DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow’s Milk Protein Allergy
Ticker: DBVT
Occurred on: Sep 21, 2016 -
Late-Breaking Presentation at EAACI Highlights Viaskin Peanut Data Providing Biomarker Insights for Monitoring Treatment Progression
Ticker: DBVT
Occurred on: Jun 15, 2016 -
DBV Technologies (DBVT) Presents CoFAR6 Phase II Results Evaluating Viaskin Peanut in Patients with Peanut Allergies
Ticker: DBVT
Occurred on: Mar 04, 2016 -
DBV Technologies (DBVT) Announces Phase Ib Trial Results for Viaskin Peanut in Patients with Peanut Allergies
Ticker: DBVT
Occurred on: Feb 25, 2016 -
DBV Technologies (DBVT) Initiates Phase III Trial Evaluating Viaskin Peanut in Children with Peanut Allergies
Ticker: DBVT
Occurred on: Dec 07, 2015
Strategic Initiatives (DBVT)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
